MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarado-Castillo, C.
Right arrow Articles by Boyer, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarado-Castillo, C.
Right arrow Articles by Boyer, J. L.

Vol. 62, Issue 3, 521-528, September 2002

A Fusion Protein of the Human P2Y1 Receptor and NTPDase1 Exhibits Functional Activities of the Native Receptor and Ectoenzyme and Reduced Signaling Responses to Endogenously Released Nucleotides

Claudia Alvarado-Castillo, Patricia Lozano-Zarain, Jesús Mateo, T. Kendall Harden, and José L. Boyer

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina (C.A.-C., P.L.-Z., J.M., T.K.H., J.L.B.); and Inspire Pharmaceuticals, Inc., Durham, North Carolina (J.L.B.)

To begin to address the functional interactions between constitutively released nucleotides, ectonucleotidase activity, and P2Y receptor-promoted signaling responses, we engineered the human P2Y1 receptor in a fusion protein with a member of the ectonucleoside triphosphate diphosphohydrolase family, NTPDase1. Membranes prepared from Chinese hamster ovary (CHO)-K1 cells stably expressing either wild-type NTPDase1 or the P2Y1 receptor-NTPDase1 fusion protein exhibited nucleotide-hydrolytic activities that were over 300-fold greater than activity measured in membranes from empty vector-transfected cells. The molecular ratio for nucleoside triphosphate versus diphosphate hydrolysis was approximately 1:0.4 for both the wild-type NTPDase1 and P2Y1-NTPDase1 fusion protein. Stable expression of the P2Y1-NTPDase1 fusion protein conferred an ADP and 2MeSADP-promoted Ca2+ response to CHO-K1 cells. Moreover, the maximal capacity of the nonhydrolyzable agonist ADPbeta S to stimulate inositol phosphate accumulation was similar, and the EC50 of ADPbeta S was lower in the fusion protein than the wild-type receptor. In contrast, the substantial nucleotide-hydrolyzing activity of the fusion protein resulted in a greater than 50-fold shift to the right of the concentration-effect curve of ADP for activation of phospholipase C compared with the wild-type receptor. Heterologous expression of the P2Y1 and other P2Y receptors results in marked increases in basal inositol phosphate levels. Given the high nucleotidase activity and apparently normal receptor signaling activity of the P2Y1 receptor-NTPDase1 fusion protein, we quantitated basal inositol phosphate accumulation in cells stably expressing either the wild-type P2Y1 receptor or the fusion protein. Although marked elevation of inositol phosphate levels occurred with wild-type P2Y1 receptor expression, levels in cells expressing the fusion protein were not different from those in wild-type CHO-K1 cells.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Alvarado-Castillo, T. K. Harden, and J. L. Boyer
Regulation of P2Y1 Receptor-Mediated Signaling by the Ectonucleoside Triphosphate Diphosphohydrolase Isozymes NTPDase1 and NTPDase2
Mol. Pharmacol., January 1, 2005; 67(1): 114 - 122.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. L. Waldo, J. Corbitt, J. L. Boyer, G. Ravi, H. S. Kim, X.-d. Ji, J. Lacy, K. A. Jacobson, and T. K. Harden
Quantitation of the P2Y1 Receptor with a High Affinity Radiolabeled Antagonist
Mol. Pharmacol., November 1, 2002; 62(5): 1249 - 1257.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics